A new antisarcoma strategy: multisubtype heat shock protein/peptide immunotherapy combined with PD-L1 immunological checkpoint inhibitors

Osteosarcoma, a common malignant tumor in orthopedics, often has a very poor prognosis after lung metastasis. Immunotherapy has not achieved much progress in the treatment because of the characteristics of solid tumors and immune environment of osteosarcoma. The tumor environment is rather essential...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, H., Sui, X., Wang, Z., Fu, H., Yuan, M., Liu, S., Wang, G., Guo, Q.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238772/
https://www.ncbi.nlm.nih.gov/pubmed/33792840
http://dx.doi.org/10.1007/s12094-021-02570-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238772/
https://www.ncbi.nlm.nih.gov/pubmed/33792840
http://dx.doi.org/10.1007/s12094-021-02570-4

Ejemplares similares